Pierwotna nadczynność przytarczyc &#8212; rzadka endokrynopatia u dzieci. Opis dwóch przypadków by Walczyk, Agnieszka et al.
346
OPIS PRZYPADKU/CASE REPORT
Endokrynologia Polska/Polish Journal of Endocrinology
Tom/Volume 62; Numer/Number 4/2011
ISSN 0423–104X
 Primary hyperparathyroidism: a rare endocrinopathy 
in children. Two case reports
Pierwotna nadczynność przytarczyc — rzadka endokrynopatia u dzieci. 
Opis dwóch przypadków
Agnieszka Walczyk1, Mieczysław Szalecki2–4, Aldona Kowalska1
1Department of Endocrinology and Nuclear Medicine, Hollycross Cancer Centre, Kielce, Poland
2Department of Endocrinology and Diabetology, Children’s Memorial Health Hospital, Warsaw, Poland
3Faculty of Health Sciences, Jan Kochanowski University, Kielce, Poland
4Department of Paediatric Endocrinology and Diabetology, Children’s Hospital, Kielce, Poland
Abstract
Primary hyperparathyroidism (PHPT) is thought to be a common disease in adults. However, it is a rare endocrine disorder in children 
and adolescents. We report two cases of primary hyperparathyroidism in children diagnosed at the Department of Endocrinology and 
Diabetes (E&D) in the Children’s Hospital (ChH), Kielce. The clinical course of the disease in these cases was fundamentally dissimilar, 
which confirms the observation that this rare endocrinopathy in children presents various clinical profiles, leading to diagnostic difficul-
ties. In the first case, the severe course of PHPT was observed with signs suggesting a hypercalcemic crisis. In the second case, the patient 
was in a good condition with a mild hypercalcemia and symptoms limited to the skeleton, due to early identification of the disease. We 
believe these cases indicate the significant role of calcemia determination as a screening test in the diagnosis of PHPT, including in children. 
(Pol J Endocrinol 2011; 62 (4): 346–350)
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Streszczenie
Pierwotna nadczynność przytarczyc (PHPT) jest częstą chorobą układu dokrewnego u dorosłych i raczej rzadką wieku dziecięcego. W pra-
cy przedstawiono dwa przypadki PHPT u dzieci zdiagnozowane na Oddziale Endokrynologiczno-Diabetologicznym Wojewódzkiego 
Specjalistycznego Szpitala Dziecięcego w Kielcach. Przebieg kliniczny choroby w obu przypadkach jest istotnie odmienny, co potwierdza 
obserwację, że ta rzadka u dzieci endokrynopatia może przybierać różny obraz i stanowić trudny problem diagnostyczny. W pierwszym 
choroba przebiegała od początku burzliwie, z objawami wręcz przełomu hiperkalcemicznego. W drugim PHPT rozpoznano wcześnie, stan 
dziecka był dobry, z umiarkowaną hiperkalcemią, objawami ograniczonymi do kośćca. Potwierdza to hipotezę o istotnej roli oznaczania 
kalcemii jako badania przesiewowego w diagnostyce PHPT, również u dzieci. (Endokrynol Pol 2011; 62 (4): 346–350)
Słowa kluczowe: pierwotna nadczynność przytarczyc u dzieci, nadciśnienie tętnicze, cukrzyca
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Introduction
Primary hyperparathyroidism (PHPT) is thought to be 
a common disease in adults. The incidence of PHPT in 
the Polish population is estimated to be up to 30 cases 
in every 100,000 [1].
However, it is a rare endocrine disorder in children 
and adolescents, with a suggested incidence of 2–5 in 
every 100,000 [2]. The clinical manifestations of PHPT 
are highly heterogenous — from the asymptomatic 
forms, through mildly symptomatic, up to a severe 
disease with end-organ damage or life-threatening 
hypercalcemic crisis [1, 2].
Serum calcium level is still not a frequent screen-
ing examination in children and adolescents. For this 
reason, in contrast to adults, 73–94% of PHPT cases in 
young patients are recognised as a symptomatic, ad-
vanced disease with multi-organ changes [2–6].
We report two cases of primary hyperparathyroidism 
in children diagnosed in the Department of Endocri-
nology and Diabetes (E&D) at the Provincial Specialist 
Children’s Hospital (PSChH) in Kielce between 2000 and 
2010. The clinical course of the disease in the two cases 
was fundamentally dissimilar, which confirms the obser-
vation that this rare endocrinopathy in children presents 
various clinical profiles, leading to diagnostic difficulties.
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Case reports
Case no. 1
A boy aged 15 years one month was admitted in July 
2002 to the Department of PE&D in Kielce with a dia-
gnosis of hypertension. The patient’s history included: 
gradual increasing of his overweight and sporadic 
infections. A month before admission, his right knee 
had been operated on due to valgity. After two weeks, 
he was hospitalised in the neurological department 
because of syncope and convulsions. A CT brain scan 
and electroencephalogram showed no abnormalities, 
but hypertension ranging from 190/90 to 150/90 was 
found. On admission to the Department of E&D, 
physical examination found a medium general con-
dition, blood pressure 165/100–180/120, overweight 
(100.5 kg), and the patient could only walk with the 
help of crutches. His height was impossible to estimate 
(he couldn’t stand unaided), and he had knee joint 
valgity with inflammatory changes in a scar on the 
right knee joint surface, and ingrowing toenails with 
inflammatory reaction. Laboratory findings showed 
i.a. increased serum calcium and intact parathormone 
(iPTH) levels (14.48 mg/dl, N. 8.8–10.6 mg/dl and 880 
pg/ml, N. 10–73pg/ml, respectively). The first serum 
phosphorus level was above the referral range, 
whereas the controlled was decreased (7.53 mg/dl 
and 1.42 mg/dl respectively, N. 4.0–7.0 mg/dl). All the 
patient’s laboratory investigations are presented in 
Table I. Features of urinary tract infection were found 
in urine analysis and confirmed by a bacteriological 
examination. 
Imaging investigations found bone age of 16 years 
with radiological signs of osteoporosis, but chest X-ray 
and ultrasound (US) of the abdominal cavity presented 
no change. In cervical US, a thyroid echostructure 
non-homogenous with hyperechogenic connective 
tissue bands was noted. A 99mTc sestamibi (MIBI) 
scan showed a zone of pathological increased activity 
in the left thyroid inferior pole and an area of slightly 
increased activity below the right thyroid lobe reach-
ing the jugular incisure of the sternum. The lumbar 
(L2-L4) bone mineral density was assessed for 1.061 
g/cm2 in dual-energy X-ray absorptiometry (DXA) 
and corresponded with a bone age-matched Z-score 
of –1.15. Diagnostics to exclude cardiological and ne-
phrological reasons for hypertension was performed, 
and all available data pointed to PHPT as the cause of 
hypertension. In medical therapy, intravenous liquids 
with forced diuresis and pamidronate disodium were 
administrated achieving calcemia, kidney parameters 
and an improvement in the patient’s state.
Concomitantly, a diabetic diet comprising 12 bread 
units (BU) daily, hypotensive treatment (enalapril, 
amlodipine), antibiotics (amoxicillin with clavulonic 
acid, mupirocin) were applied and inflammatory 
infiltrations around the toenails were evacuated. 
Finally, correct blood pressure control, body mass 
reduction to 90 kg, and the regression of coexisting 
infections were obtained. The patient was referred 
for surgery. The enlarged (20 × 30 mm) inferior right 
parathyroid gland and thymus were removed because 
of adenoma’s connection with its superior pole. The 
result of histopathological examination: Thymus tis-
sue. Adenoma glandulae parathyreoideae. On the third 
day after the operation, normalisation of calcemia was 
observed. After two months, normal blood pressure 
without hypotensive treatment was noted, as well as 
bodyweight of 92.5 kg, correct tolerance of glucose, 
normocalcemia during requiring calcium and vita-
min D3 supplements (3 000 mg elementary calcium 
and alfacalcidol 2.5 μg daily), appropriate iPTH at 
decreased 25OHD3 and 1.25(OH)2D3 vitamin levels 
were acquired. DXA densitometry did not present low 
bone mineral density after 12 months (1.434 g/cm2) 
with a bone age-matched Z-score of +2.0. 
During follow-up, the patient reached a normal 
physical efficiency, hypertension and carbohydrate 
metabolism disorders were not observed. At the age 
Table I. Case no. 1. Results of laboratory investigations at 
the diagnosis of PHPT
Tabela I. Przypadek nr 1. Wyniki badań w chwili rozpoznania 
pierwotnej nadczynności przytarczyc
Before surgery
Leucocytes [G/l] 15.5
Thrombocytes [G/l] 579
Sodium [N. 136–146 mEq/l] 135.5–127.5
Potassium [N. 3.5–5.1 mEq/l] 3.67–3.37
Total calcium [N. 8.8–10.6 mg/dl] 14.48–14.6
Calcium ++ [N. 1.1–1.32 mmol/l] 2.12-2.55
Phosphorus [N. 4.0–7.0 mg/dl] 7.53–1.42
Magnesium [N. 1.8–2.6 mg/dl] 1.69
Urea [mg/dl] 66.9
Creatinine [mg/dl] 1.42–1.69
Endogenous creatinine clearance [ml/min] 108.62 (day)
Endogenous creatinine clearance [ml/min] 98.86 (night)
OGTT: glucose 0’–120’ [mg/dl] 90.3–174.4
OGTT: insulin 0’–120’ [μIU/ml] 23.7–325.0
Intact PTH [N. 10–73 pg/ml] 880
TSH [N. 0.39–4.62 IU/ml] 0.39
FreeT4 [N. 0.78–2.11 ng/ml] 1.03
OGTT — oral glucose tolerance test
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of 18 years and eight months, the patient was 185 cm 
tall and weighed 82 kg and he was referred to con-
tinue control to the Endocrinology Outpatient Clinic 
of Hollycross Cancer Centre (Świętokrzyskie Centrum 
Onkologii) in Kielce.
Case no. 2
A girl aged four years four months was admitted for the 
first time in February 2003 to the Department of PE&D 
in Kielce with a diagnosis of short stature. History: the 
child had been born at 39 Hbd of 2nd pregnancy and 
2nd delivery with a birthweight of 2,850 g and a length 
of 51 cm. So far she had been healthy. Her mother was 
157.5 cm tall and her father 168 cm. Objectively: height 
92.2 cm (under 3rd percentile), weight 11.8 kg (3rd–10th 
percentile), in examinations — no growth hormone 
(GH) secretion abnormalities after insulin and clonidine 
stimulation were found, bone age 36/12 years. Deter-
mined total calcium level was normal (9.64 mg/dl, N. 
8.8–10.6 mg/dl).
Initially, an idiopathic short stature was recog-
nised, and the patient was recommended for monitor-
ing of growth and body mass. After 20 months, at the 
age of six years, DXA densitometry was performed 
because of suspected osteopenia noticed in a wrist 
joint X-ray. Lumbar (L2–L4) measurements indicated 
a bone mineral density at level 0.370 g/cm2, but Z-
score was not calculated because of an absence of 
reference values for a bone age below five years. The 
result satisfied densitometric criteria of osteoporo-
sis. After 12 months, lumbar (L2-L4) DXA result 
showed an inappropriately low bone mineral density 
to gender and age of 0.434g/cm2 (a bone age-matched 
Z-score of –2.16). Normocalcemia was observed again 
(10.12 mg/dl).
Oral calcium and vitamin D3 were adminis-
tered as treatment. After 14 months, hypercalcemia 
(12.36 mg/dl) was noted despite the fact the medicines 
were not taken. Thus, in January 2007, the child aged 8 
years two months was referred for hospital diagnostics 
due to the suspicion of primary hyperparathyroid-
ism with short stature and body mass deficiency. The 
follow-up, which lasted for 3 years and 10 months for 
the diagnosis of PHPT, is presented in Table II. On 
admission to the hospital, the patient’s general condi-
tion was good. At the same time, a profile of night GH 
secretion was performed with results of all GH points 
under 10 ng/ml, insulin-like growth factor-1 (IGF-1) 
was appropriate to age and gender. Cervical US found 
no abnormalities. A 99mTc/MIBI scan indicated areas 
of pathological increased activity in the left thyroid 
inferior pole, whereas the subtraction technique found 
areas of increased activity in both thyroid superior 
poles and the left side of the isthmus. Clinical and 
molecular diagnostics were performed which excluded 
the features of multiple endocrine neoplasia syndrome 
(MEN) associated with germ line mutation of the RET 
protooncogene. Normocalcemia was achieved due 
to intravenous liquids and pamidronate administra-
tion  every month. Finally, the patient was diagnosed 
with PHPT and referred for surgery. In April 2007, 
during the neck exploration connected with intraop-
erative histopathological examination, an enlarged 
right superior parathyroid gland and a not enlarged 
Table II. Case no. 2. Summary of patient’s follow-up to the diagnosis of PHPT
Tabela II. Przypadek nr 2. Podsumowanie obserwacji dziecka od pierwszego badania do rozpoznania PHPT
Follow-up 0’ 1 year 8 months 2 years 8 months 3 years 10 months
Chronological age 4 4/12 6 7 8 2/12
Height [cm] (percentile] 92.2 (< 3] 103 (< 3] 108 (< 3] 113 (< 3)
Weight [kg] (percentile] 11.8 (3–10] 13.4 (3–10] 14.8 (3–10] 16 (3–10)
Bone age 3 6/12 4 6/12 6 6/12 7
Serum Ca [N. 8.8–10.6 mg/dl] 9.64 10.05 10.12 12.36–12.44
Serum PO4 [N. 4.0–7.0 mg/dl] (–) 4.25 4.30 3.3–1.94
Urine Ca [N. 1–4 mg/kg/d] (–) 1.24 4.32 12.9
Urine PO4 [N. 15–20 mg/kg/d] (–) 20.14 17.43 26.78
Serum Mg [N. 1.8–2.6 mg/dl] (–) 2.48 2.38 2.07
Urine Mg [N. 2 –3.6 mg/kg/d] (–) 2.57 3.82 4.48
BMD L2–L4 [g/cm2] (–) 0.370 0.434 0.423
Intact PTH [N. 10–69 pg/ml] (–) (–) (–) 112
ALP [N. 69–315 U/l] (–) (–) (–) 257
BMD — bone mineral density; ALP — alkaline phosphatase
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right inferior parathyroid gland were removed. The 
result of histopathological examination: Superior right 
parathyroid gland — adenoma glandulae parathyreoideae. 
After the surgery, neither severe hypocalcaemia nor 
“hungry bone syndrome” were observed, and calcium 
and vitamin D3 supplements were administered. On 
the fifth day after the operation, normocalcemia and 
normophosphatemia were noted. Six months later, 
serum calcium and phosphorus levels, calciuria and 
phosphaturia were appropriate during calcium supple-
mentary; lumbar (L2–L4) DXA densitometry indicated 
BMD at level 0.529 g/cm2 (a bone age-matched Z-score 
of –1.46), and iPTH was correct. In the tenth year of 
life there were still no pathological changes of calcium 
and phosphate metabolism during the treatment of 
1,000 mg elementary calcium and alfacalcidol 0.25 μg 
daily, whereas short stature and body mass deficiency 
(height under 3rd percentile, weight — 10th percentile) 
were observed. A decrease of IGF-1 to 34.3 ng/ml (N. 
to age and gender: 175–445) was presented. The per-
formed diagnostics showed GH secretion deficiency 
after insulin and clonidine stimulation (GH < 10 ng/ml 
in all points of the tests). Therefore somatotropic pi-
tuitary insufficiency was recognised. In October 2009, 
the GH therapy was started with a good clinical result. 
The course of the growth process in this case is set out 
in Figure 1.
Discussion
Primary hyperparathyroidism occurs rarely in chil-
dren. In the last decade, only two cases were diagnosed 
in the Department of PE&D in Kielce. Difficulty in 
establishing an early diagnosis is due to both non-spe-
cific complaints — nausea, abdominal pain, vomiting, 
fatigue, decreased appetite, weight loss, constipation, 
osteomuscular pains, learning disability dependent on 
the development of hypercalcaemia, and the absence 
of symptoms in the initial phase of the rare occur-
rence of PHPT in people aged below 18 years. An 
uncommon measurement of serum calcium in an ap-
parently healthy child or failure it in a diagnostics of 
long-lasting or rarely acute disorders results in PHPT 
recognition as an advanced disease [2, 3, 7, 8]. The 
patient reported in Case no.1 was hospitalised twice 
within a month before the diagnosis of PHPT, including 
once because of skeletal disease and the assessment 
of calcemia was not performed then. It should also 
be assumed that neurological manifestations induc-
ing hospitalisation were probably the consequence of 
severe hypertension in the course of an unrecognised 
hypercalcemic crisis.
Hypertension is not a frequent symptom of PHPT. It 
occurs in approximately 20–50% of patients, most often 
with coexisting kidney disorders [9]. Most data in the 
literature concerns adult observations. The available 
studies of groups of children and adolescents allow 
us to regard hypertension as a rather rare symptom of 
PHPT in this age group — from 0% to 14% [2–4, 10]. 
Loh et al. [10] suggests that hypertension occurs more 
often with increasing age: in a group of seven patients 
aged ≤ 18 years it was recognised in one patient (1/7; 
14%), whereas in a group of 15 patients aged 19 to 28 
years it was recognised in four patients (4/15; 27%), 
which corresponds with the prevalence of hyperten-
sion found in the adult population. In most reports, the 
authors agree that children diagnosed with PHPT often 
suffer from multi-organ damage. At present, nephro-
lithiasis is known to be a result of increased secretion 
of PTH in 5–7% of adults [1, 11]. However, in children, 
nephrological symptoms presenting as renal calculosis 
have been observed in 33–54%, nephrocalcinosis in 
8–16%, and renal failure in single patients [2–6]. In our 
Case no. 1, renal dysfunction without coexisting neph-
rolithiasis was observed. Therefore it can be assumed 
that it was a sign of dehydration in the course of PHPT 
emergent as a hypercalcemic crisis. 
Both in adults and in children, PHPT is rarely 
recognised in such a life-threatening phase [1, 4, 
5].  A classic bone disease with osteitis fibrosa cystica 
is rare, being recognised in less than 10% of adult 
patients [1]. Therefore, due to the fact that PHPT in 
Figure 1. Growth percentile chart presenting the patient’s growing 
process in Case no. 2 
Rycina 1. Obserwacja wzrastania dziecka z przypadku nr 2 
przedstawiona w siatce centylowej wysokości dziewcząt
Cm
Age (years) Age (months)
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nt
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s
Ce
nt
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s
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children and adolescents is usually diagnosed late, we 
should expect advanced bone changes to be common. 
However, osteopenia, osteoporosis and subperiosteal 
resorption were the most often encountered skeletal 
symptoms described in the studies, which emphasised 
a high percentage of bone changes (16–63% reported 
by different authors) which confirms late diagnoses of 
the disease [2–5]. But some authors, such as George et 
al., found bone pains in 86% of patients, fractures in 
60%, and palpable osteitis fibrosa cystica in 33.3%, which 
could possibly result from the geographical and social 
conditions of the studied group of 15 children with 
PHPT living in India [12]. Low bone mass features 
were present in both the cases we describe, but in the 
girl, although PHPT was early identified, it was more 
advanced than in the boy, and she was suffering from 
a severe multi-organ disease.
In our Case no. 1, PHPT and glucose metabolism 
disorders without pancreatitis were diagnosed concomi-
tantly. Diabetes in PHPT usually appears in the course 
of pancreatitis as a consequence of hypercalcemia [1, 
13]. Recent data suggests the presence of lower insulin 
sensitivity and hyperinsulinism in adults with PHPT, 
but significantly higher prevalence of type 2 diabetes 
mellitus has been documented in older patients (aged 
64–75 years) and in men generally [14]. Additionally, 
a higher calcium level is proposed as an independent 
predictor of metabolic syndrome and insulin resistance 
[15]. There is no unequivocal data showing that children 
and adolescents aged under 18 might present the same 
correlations. Nevertheless, it would seem to be useful 
to control glucose and lipid metabolism in the patient 
reported as Case no. 1 to evaluate cardiovascular risk 
factors in the future, despite the disappearance of 
impaired glucose tolerance after successful surgery. In 
the available literature, growth inhibition in children 
of post-infantile age with PHPT has not been reported 
[2–6, 10]. The short stature in our Case no. 2 was an effect 
of coexisting somatotropic hypopituitarism. Successful 
surgery of PHPT did not improve the growth, which 
was not observed only after the introducing to the GH 
therapy. It is worth noting the early diagnosis of PHPT 
in this case. The patient was in a good condition with 
a mild hypercalcemia and symptoms limited to the 
skeleton at the moment of diagnosis. It confirms our 
hypothesis of the significant role of calcemia deter-
mination as a screening test in the diagnosis of PHPT, 
including in children.
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